Patent US6048873A successfully refreshed from Google Patents.
US6048873A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Tetrahdroquinolin-2-one 6 or 7-yl, tetrahdroquinilin-2-thione 6 or 7-yl pentadienoic acid and related derivatives having retinoid-like biological activity
Assignee: Allergan Inc
•
Filing: 1998-10-01
•
Granted: 2000-04-11
•
Expires: 2018-10-01
Abstract
Abstract Compounds of Formula 1 ##STR1## where Y is a bivalent radical having Formula 2 or Formula 3 where o is an integer from 1 to 4 ##STR2## where the remaining symbols have the meaning described in the specification are selective agonists of RXR retinoid receptors.
Inventors
- 👤 Jayasree Vasudevan
- 👤 Vidyasagar Vuligonda
- 👤 Richard L. Beard
- 👤 Roshantha A. Chandraratna
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 06:43
CPC Classifications
C; C07; C07D; C07D215/00; C07D215/02; C07D215/12; A; A61; A61P; A61P1/00; A61P1/04; A61P17/00; A61P17/14; A61P25/00; A61P25/14; A61P25/16; A61P25/28; A61P27/00; A61P27/02; A61P29/00; A61P3/00; A61P3/06; A61P31/00; A61P31/12; A61P35/00; A61P37/00; A61P37/02; A61P39/00; A61P39/02; A61P43/00; A61P5/00; A61P5/10; A61P9/00; C07D215/16; C07D215/20; C07D215/22; C07D215/36; C07D405/00; C07D405/02; C07D405/04
Claims Analysis
Total Claims: 27
Claim 1
Independent Claim
396 words
A compound of Formula 1 ##STR11## where Y is a bivalent radical having Formula 3 ##STR12## the two X 1 groups jointly represent an oxo (═O) or thione (═S) function, or X 1 is independently selected from H or alkyl of 1 to 6 carbons; the two X 2 groups jointly represent an oxo (═O) or a thione (═S) function, or X 2 is independently selected from H or alkyl of 1 to 6 carbons, with the proviso that one of the joint X 1 grouping or of the joint X 2 grouping represents an oxo (═O) or a thione (═S) function; W is O, C(R 1 ) 2 , or W does not exist; R 1 is independently H, lower alkyl of 1 to 6 carbons, or lower fluoroalkyl of 1 to 6 carbons; R 2 is independently H, lower alkyl of 1 to 6 carbons, or lower fluoroalkyl of 1 to 6 carbons; R 3 is hydrogen, lower alkyl of I to 6 carbons, OR 1 , fluoro substituted lower alkyl of 1 to 6 carbons or halogen, NO 2 , NH 2 , NHCO(C 1 -C 6 alkyl, or NHCO(C 1 -C 6 )alkenyl; A is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR 8 , CONR 9 R 10 , --CH 2 OH, CH 2 OR 11 , CH 2 OCOR 11 , CHO, CH(OR 12 ) 2 , CH(OR 13 O), --COR 7 , CR 7 (OR 12 ) 2 , CR 7 (OR 13 O), or Si(C 1-6 alkyl) 3 , where R 7 is an alkyl, cycloalkyl or alkenyl group containing 1 to 5 carbons, R 8 is an alkyl group of 1 to 10 carbons or (trimethylsilyl)alkyl where the alkyl group has 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R 8 is phenyl or lower alkylphenyl, R 9 and R 10 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5-10 carbons, or phenyl, hydroxyphenyl or lower alkylphenyl, R 11 is lower alkyl, phenyl or lower alkylphenyl, R 12 is lower alkyl, and R 13 is divalent alkyl radical of 2-5 carbons, and R 14 is H, alkyl of 1 to 10 carbons, fluoro-substituted alkyl of 1 to 10 carbons, alkenyl of 2 to 10 carbons and having 1 to 3 double bonds.
Claim 2
Dependent Claim
396 words
A compound of Formula 1 ##STR11## where Y is a bivalent radical having Formula 3 ##STR12## the two X 1 groups jointly represent an oxo (═O) or thione (═S) function, or X 1 is independently selected from H or alkyl of 1 to 6 carbons; the two X 2 groups jointly represent an oxo (═O) or a thione (═S) function, or X 2 is independently selected from H or alkyl of 1 to 6 carbons, with the proviso that one of the joint X 1 grouping or of the joint X 2 grouping represents an oxo (═O) or a thione (═S) function; W is O, C(R 1 ) 2 , or W does not exist; R 1 is independently H, lower alkyl of 1 to 6 carbons, or lower fluoroalkyl of 1 to 6 carbons; R 2 is independently H, lower alkyl of 1 to 6 carbons, or lower fluoroalkyl of 1 to 6 carbons; R 3 is hydrogen, lower alkyl of I to 6 carbons, OR 1 , fluoro substituted lower alkyl of 1 to 6 carbons or halogen, NO 2 , NH 2 , NHCO(C 1 -C 6 alkyl, or NHCO(C 1 -C 6 )alkenyl; A is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR 8 , CONR 9 R 10 , --CH 2 OH, CH 2 OR 11 , CH 2 OCOR 11 , CHO, CH(OR 12 ) 2 , CH(OR 13 O), --COR 7 , CR 7 (OR 12 ) 2 , CR 7 (OR 13 O), or Si(C 1-6 alkyl) 3 , where R 7 is an alkyl, cycloalkyl or alkenyl group containing 1 to 5 carbons, R 8 is an alkyl group of 1 to 10 carbons or (trimethylsilyl)alkyl where the alkyl group has 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R 8 is phenyl or lower alkylphenyl, R 9 and R 10 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5-10 carbons, or phenyl, hydroxyphenyl or lower alkylphenyl, R 11 is lower alkyl, phenyl or lower alkylphenyl, R 12 is lower alkyl, and R 13 is divalent alkyl radical of 2-5 carbons, and R 14 is H, alkyl of 1 to 10 carbons, fluoro-substituted alkyl of 1 to 10 carbons, alkenyl of 2 to 10 carbons and having 1 to 3 double bonds.
Claim 3
Dependent Claim
22 words
A compound in accordance with claim 1 where the two X 1 groups jointly represent an oxo (═O) or thione (═S) function.
Claim 4
Dependent Claim
23 words
A compound in accordance with claim 1 where the two X 2 groups jointly represent an oxo (═O) or a thione (═S) function.
Claim 5
Dependent Claim
214 words
A compound of the formula ##STR13## wherein R 1 is independently H, lower alkyl of 1 to 6 carbons, or lower fluoroalkyl of 1 to 6 carbons; R 1 * is hydrogen or C 1-6 -alkyl; R 2 * is independently H, lower alkyl of 1 to 6 carbons, or lower fluoroalkyl of 1 to 6 carbons; R 3 * is hydrogen, lower alkyl of 1 to 6 carbons, fluoro substituted lower alkyl of 1 to 6 carbons or halogen; X 1 * is an oxo (═O) or a thione (═S) group; A* is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR 8 , CONR 9 R 10 , where R 8 is an alkyl group of 1 to 10 carbons or (trimethylsilyl)alkyl where the alkyl group has 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R 8 is phenyl or lower alkylphenyl, R 9 and R 10 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5-10 carbons, or phenyl, hydroxyphenyl or lower alkylphenyl, and the cyclopropyl group is attached to the 6 or 7 position of the tetrahydroquinoline moiety, and R 14 * is alkyl of 1 to 10 carbons or fluoro-substituted alkyl of 1 to 10 carbons.
Claim 6
Dependent Claim
214 words
A compound of the formula ##STR13## wherein R 1 is independently H, lower alkyl of 1 to 6 carbons, or lower fluoroalkyl of 1 to 6 carbons; R 1 * is hydrogen or C 1-6 -alkyl; R 2 * is independently H, lower alkyl of 1 to 6 carbons, or lower fluoroalkyl of 1 to 6 carbons; R 3 * is hydrogen, lower alkyl of 1 to 6 carbons, fluoro substituted lower alkyl of 1 to 6 carbons or halogen; X 1 * is an oxo (═O) or a thione (═S) group; A* is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR 8 , CONR 9 R 10 , where R 8 is an alkyl group of 1 to 10 carbons or (trimethylsilyl)alkyl where the alkyl group has 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R 8 is phenyl or lower alkylphenyl, R 9 and R 10 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5-10 carbons, or phenyl, hydroxyphenyl or lower alkylphenyl, and the cyclopropyl group is attached to the 6 or 7 position of the tetrahydroquinoline moiety, and R 14 * is alkyl of 1 to 10 carbons or fluoro-substituted alkyl of 1 to 10 carbons.
Claim 7
Dependent Claim
15 words
A compound in accordance with claim 4 where R 2 * is CH 3 .
Claim 8
Dependent Claim
16 words
A compound in accordance with claim 5 where R 1 is H or CH 3 .
Claim 9
Dependent Claim
13 words
A compound in accordance with claim 6 where R 3 * is H.
Claim 10
Dependent Claim
19 words
A compound in accordance with claim 7 where R 14 * is lower alkyl of 1 to 6 carbons.
Claim 11
Dependent Claim
21 words
A compound in accordance with claim 8 where the cyclopropyl group is attached to the 6 position of the tetrahydroquinoline moiety.
Claim 12
Dependent Claim
25 words
A compound in accordance with claim 9 where the configuration about the cyclopropyl ring is cis, and the configurations about the double bonds are trans.
Claim 13
Dependent Claim
21 words
A compound in accordance with claim 10 where A* is COOH or a pharmaceutically acceptable salt thereof, or COOR 8 .
Claim 14
Dependent Claim
13 words
A compound in accordance with claim 11 where R 14 * is iso-propyl.
Claim 15
Dependent Claim
13 words
A compound in accordance with claim 12 where R 1 * is methyl.
Claim 16
Dependent Claim
26 words
A compound in accordance with claim 4, selected from the group consisting of: (6S,7S)-7-(4,4-dimethyl-2-oxo-1-(2-propyl)-1,2,3,4-tetrahydroquinolin-6-yl)-6,7-methano-3-methyl-octa-2E,4E-dienoic acid, (6S,7S)-7-(4,4-dimethyl-2-oxo-1-(2-propyl)-1,2,3,4-tetrahydroquinolin-6-yl)-6,7-methano-3-methyl-octa-2E,4E-dienoic acid ethyl ester, (6S,7S)-7-(4,4-dimethyl-1-(2-propyl)-2-thioxo-1,2,3,4-tetrahydroquinolin-6-yl)-6,7-methano-3-methyl-octa-2E,4E-dienoic acid ethyl ester, and (6S,7S)-7-(4,4-dimethyl-1-(2-propyl)-2-thioxo-1,2,3,4-tetrahydroquinolin-6-yl)-6,7-methano-3-methyl-octa-2E,4E-dienoic acid.
Claim 17
Dependent Claim
241 words
A compound of the formula ##STR14## wherein R 1 is independently H, lower alkyl of 1 to 6 carbons, or lower fluoroalkyl of 1 to 6 carbons; R 1 * is hydrogen or C 1-6 -alkyl; R 2 * is independently H, lower alkyl of 1 to 6 carbons, or lower fluoroalkyl of 1 to 6 carbons; R 3 * is hydrogen, lower alkyl of 1 to 6 carbons, fluoro substituted lower alkyl of 1 to 6 carbons or halogen; X 2 * is an oxo (═O) or a thione (═S) group; A* is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR 8 , CONR 9 R 10 , where R 8 is an alkyl group of 1 to 10 carbons or (trimethylsilyl)alkyl where the alkyl group has 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R 8 is phenyl or lower alkylphenyl, R 9 and R 10 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5-10 carbons, or phenyl, hydroxyphenyl or lower alkylphenyl, and the cyclopropyl group is attached to the 6 or 7 position of the tetrahydroquinoline moiety, W* O, CH or CH 2 , with the proviso that when W* is CH then there are two R 14 * groups attached to it, and R 14 * is H, alkyl of 1 to 10 carbons or fluoro-substituted alkyl of 1 to 10 carbons.
Claim 18
Dependent Claim
241 words
A compound of the formula ##STR14## wherein R 1 is independently H, lower alkyl of 1 to 6 carbons, or lower fluoroalkyl of 1 to 6 carbons; R 1 * is hydrogen or C 1-6 -alkyl; R 2 * is independently H, lower alkyl of 1 to 6 carbons, or lower fluoroalkyl of 1 to 6 carbons; R 3 * is hydrogen, lower alkyl of 1 to 6 carbons, fluoro substituted lower alkyl of 1 to 6 carbons or halogen; X 2 * is an oxo (═O) or a thione (═S) group; A* is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR 8 , CONR 9 R 10 , where R 8 is an alkyl group of 1 to 10 carbons or (trimethylsilyl)alkyl where the alkyl group has 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R 8 is phenyl or lower alkylphenyl, R 9 and R 10 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5-10 carbons, or phenyl, hydroxyphenyl or lower alkylphenyl, and the cyclopropyl group is attached to the 6 or 7 position of the tetrahydroquinoline moiety, W* O, CH or CH 2 , with the proviso that when W* is CH then there are two R 14 * groups attached to it, and R 14 * is H, alkyl of 1 to 10 carbons or fluoro-substituted alkyl of 1 to 10 carbons.
Claim 19
Dependent Claim
15 words
A compound in accordance with claim 15 where R 2 * is CH 3 .
Claim 20
Dependent Claim
16 words
A compound in accordance with claim 16 where R 1 is H or CH 3 .
Claim 21
Dependent Claim
13 words
A compound in accordance with claim 17 where R 3 * is H.
Claim 22
Dependent Claim
19 words
A compound in accordance with claim 18 where R 14 * is lower alkyl of 1 to 6 carbons.
Claim 23
Dependent Claim
25 words
A compound in accordance with claim 19 where the configuration about the cyclopropyl ring is cis, and the configurations about the double bonds are trans.
Claim 24
Dependent Claim
21 words
A compound in accordance with claim 20 where A* is COOH or a pharmaceutically acceptable salt thereof, or COOR 8 .
Claim 25
Dependent Claim
15 words
A compound in accordance with claim 21 where R 14 * is methyl or tertiary-butyl.
Claim 26
Dependent Claim
13 words
A compound in accordance with claim 22 where R 1 * is methyl.
Claim 27
Dependent Claim
32 words
A compound in accordance with claim 15, selected from the group consisting of: (6S,7S)-7-(1-(tert-butyloxycarbonyl)-4,4-dimethyl-1,2,3,4-tetrahydroquinolin-6-yl)-6,7-methano-3-methyl-octa-2E,4E-dienoic acid, (6S,7S)-7-(1-(tert-butyloxycarbonyl)-4,4-dimethyl-1,2,3,4-tetrahydroquinolin-6-yl)-6,7-methano-3-methyl-octa-2E,4E-dienoic acid ethyl ester, (6S,7S)-7-(1-(Acetyl)-4,4-dimethyl-1,2,3,4-tetrahydro-quinolin-6-yl)-6,7-methano-3-methyl-octa-2E,4E-dienoic acid, (6S,7S)-7-(1-Acetyl-4,4-dimethyl-1,2,3,4-tetrahydro-quinolin-6-yl)-6,7-methano-3-methyl-octa-2E,4E-dienoic acid ethyl ester, (6S,7S)-1-Acetyl-4,4-dimethyl-1,2,3,4-tetrahydroquinolin-7-yl)-6,7-methano-3-methyl-octa-2E,4E-dienoic acid, and (6S,7S)-7-(1-Acetyl-4,4-dimethyl-1,2,3,4-tetrahydroquinolin-7-yl)-6,7-methano-3-methyl-octa-2E,4E-dienoic acid ethyl ester.
References Cited (Backward Citations)
US5750693A
Cited
WO1993011755A1
Cited
WO1993021146A1
Cited
WO1995004036A1
Cited
US5455265A
Cited
US5616712A
Cited
US5663367A
Cited
US5675033A
Cited
WO1996039374A1
Cited
US5817836A
Cited
WO1997009297A2
Cited
WO1997012853A1
Cited
US5672710A
Cited
US5739338A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2003-04-11 | 2003-10-11 | 2004-04-11 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2007-04-11 | 2007-10-11 | 2008-04-11 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2011-04-11 | 2011-10-11 | 2012-04-11 | $7700.00 | Window Closed / Lapsed |